Caroline Gaudy-Marqueste

Nivolumab for Resected Stage III or IV Melanoma at 9 Years.

Nivolumab plus relatlimab in gevorderd melanoma: RELATIVITY-047 4-year update.

Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in pa...

Definitieve tienjaars uitkomsten met nivolumab plus ipilimumab bij gevorderd melanoom: CheckMate 067